
Shanghai, China, 07 July, 2025 - MicroPort® MedBot™ is excited to share that its Toumai® Endoscopic Surgical Robot (Toumai®) has been honored with “Groundbreaking Technology” award at the Surgical Robotics Industry Awards 2025, a key global recognition for excellence in surgical robotics innovation. This recognition underscores Toumai®’s technological innovation and clinical excellence.

Hosted by Surgical Robotics Technology (SRT), a globally recognized media platform dedicated to surgical robotics, the award highlights industry leaders advancing the future of surgical care.
To date, Toumai® has been approved in more than 30 countries and regions worldwide and continues to lead the way in remote surgery innovation. In April this year, it became the first surgical robot globally to receive multi-specialty regulatory approval for remote surgery applications, a milestone in the evolution of tele-surgical care.
Dr. Alex He, President of MicroPort® MedBot™, commented: “We strive to connect lives through technology, reshape equity through innovation, and work hand in hand with global partners to build a smarter, more accessible, and more equitable surgical robotics ecosystem.”
-
2025-11-14Toumai® Robotic Fluorescence Imaging System Receives EU CE Certification -
2025-11-10MicroPort® MedBotTM Showcases Toumai® Surgical Robot at “China Sci-Tech Innovation Gala”! -
2025-10-13Toumai® Robot Assists in Complex Pancreaticoduodenectomy with SMV Resection and Prosthetic Graft Reconstruction






Hu ICP Bei No. 20013662 HGWA Bei No. 31011502015178
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd.” . They have been authorized to be used by Shanghai Microport Medbot (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
